Germany – Pharmaceutical products – Abschluss eines nicht-exklusiven Rabattvertrages gemäß § 130c Abs. 1 SGB V zwischen der IKK classic und der CC Pharma GmbH zu Emgality
awardedIKK classic · 993-80175-34
Description
Abschluss eines nicht-exklusiven Rabattvertrages gemäß § 130c Abs. 1 SGB V zwischen der IKK classic und der CC Pharma GmbH zu Emgality (ATC-Code: N02CD02)
Key facts
- Procedure
- neg-wo-call
- Contract period
- 1 Dec 2026 → 30 Nov 2028
- Regime
- publicSector
- Contract references
- Abschluss eines nicht-exklusiven Rabattvertrages gemäß § 130c Abs. 1 SGB V zwischen der IKK classic und der CC Pharma GmbH zu Emgality
- Category
- supplies
Awarded suppliers
- CC Pharma GmbH · DEB24, DE
Supplier location as published: Densborn, DEB24, 54570, DE
Ground given for limiting competition
The buyer’s own stated reason for awarding without open competition, as published. Their assertion, not a finding.
exclusive
Der Vertrag sichert ausdrücklich keine Exklusivität zu. Die Vertragspartner werden nicht gehindert weitere Verträge auf der Grundlage von § 130c Abs. 1 SGB V auch mit anderen Vertragspartnern zu schließen
What a subscription adds to this notice
- The documents — every attachment, with its text extracted and searchable
- Qualification — the notice scored against your company profile
- Tracking and alerts — a pipeline for your bids, and the matching notices by email
- The API and MCP — the same record in your own tools and your AI assistant
Provenance
- Source
- ted-eu
- Notice id
- 784548-2026
- First seen
- 11 Nov 2026
- Last updated
- 11 Nov 2026
Licence EU reuse — Commission Decision 2011/833/EU ↗
Source: TED — Tenders Electronic Daily (ted.europa.eu), © European Union, reused under Commission Decision 2011/833/EU.
GET /api/v1/tenders/61f90980-97f3-44b3-b8f9-1161eacbaef8The source notice is authoritative — verify deadlines and documents there before bidding.